Authors
Latest:
Takeaways from NASP: The State of Pricing Reform Efforts and AI Decision Support in Specialty PharmacyThe National Association of Specialty Pharmacy's annual meeting is one of the industry’s only conferences where all stakeholders can fully participate.
Latest:
Homeopathic Products: A Growing Segment in OTC?Homeopathy is becoming increasingly complementary to allopathic medicine.
Latest:
Predictors of Healthcare Costs After Initiating Dabigatran Versus WarfarinThe study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
Latest:
Students' Engagement Key to Making an Rximpact for PharmacyWe know that the future of pharmacy rests in large part in the hands of pharmacy students.
Latest:
Schizophrenia Costs for Newly Diagnosed Versus Previously Diagnosed PatientsPreviously diagnosed schizophrenia patients have lower inpatient and higher drug costs compared with newly diagnosed patients, possibly indicating better control of their disease.
Latest:
The Impact of Coronavirus on Pharmacy Students Beginning APPE RotationsStudent pharmacists across the country have had to adjust their expectations of what P4 year will look like.
Latest:
What Is the Pharmacist's Continued Role in Preventing Herpes Zoster?Community pharmacists have become an integral part of the fight to prevent herpes zoster (shingles).
Latest:
Web Exclusive: Pharmacist Glycemic Control Team Associated With Improved Perioperative Glycemic and Utilization OutcomesImplementation of a pharmacist-led glycemic control team was associated with improved glycemic control and utilization outcomes in a population of noncritically ill surgical patients.
Latest:
Niche Services and the Road Less TakenIt's not enough to commit to change, you must commit to always changing: a life rule that this pharmacist has embraced.
Latest:
Selecting Your APPE Rotations to Better Prepare for Residency TrainingSelecting your Advanced Pharmacy Practice Experiences (APPEs) rotations can be both exhilarating and overwhelming.
Latest:
Case Study: Technology Provides Solution to Challenge with Annual Benefit VerificationsThe ability to automate a medical benefit investigation is bringing new efficiencies to the hub and delivering better outcomes for providers, patients, and manufacturers.
Latest:
Weave Pharmacogenomics Drug-Gene Interactions Into MTMKeep a critical eye on whether precautions should be taken or a change in therapy is warranted.
Latest:
Perspectives From Pharmacists, Educators on the Frontlines of COVID-19 ImmunizationsAs a majority of advanced pharmacy practice experiences need to include direct patient care, immunizing provides students an opportunity to provide this care along with consultation around the COVID-19 vaccine and adverse effects.
Latest:
Shared Decision Making Reduces Post-Hysterectomy Opioid PrescribingShared decision making is a tool used by health care professionals to educate more thoroughly, and communicate with their patients.
Latest:
Shionogi Pharma's KapvayThe FDA approved Kapvay (clonidine hydrochloride extended -release) as a monotherapy and adjunctive therapy for the treatment of attention- deficit/hyperactivity disorder in children and adolescents aged 6 to 17 years.
Latest:
How Pharmacies Can Improve Reimbursement for Oncology DrugsPharmacists can play a role in the drug reimbursement process for oncology products, which are among the most expensive of all pharmaceuticals.
Latest:
Trends in High-Cost Generic Drug Utilization and SpendThe prevalence and proportion of spend on high-cost generic drugs is examined.
Latest:
Nonprescription Medication TrendsNonprescription medications provide $102 billion in value to the US health care system annually.
Latest:
Evaluating the Efficacy of Adjunctive Therapies Used to Treat COVID-19: The Role of Famotidine, Melatonin, and ThiamineH2-receptor antagonists, melatonin, and thiamine are some of the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.
Latest:
The Brave New World of 340B: Where Do We Go From Here?It's been nearly a year since the new 340B payment rule implemented by the Centers for Medicare and Medicaid Services went into effect.
